quinaprilat has been researched along with Cardiac Failure in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Felix, SB; Kieback, AG; Reffelmann, T | 1 |
| Bernecker, OY; Fellner, B; Franz, M; Hallström, S; Kröner, A; Neumüller, J; Podesser, BK; Schirnhofer, J; Semsroth, S; Wolner, E | 1 |
| Baumann, G; Felix, SB; Grohmann, A; Kieback, AG | 1 |
| Bammert-Adams, JA; Begg, EJ; Ikram, H; Olson, SC; Posvar, EL; Reece, PA; Richards, AM; Robson, RA; Sedman, AJ | 1 |
| Bakovic-Alt, R; Bonzel, T; Mitrovic, V; Mudra, H; Posvar, EL; Schmidt, W; Strand, JC | 1 |
| Bonzel, T; Mitrovic, V; Mudra, H; Schlepper, M; Schmidt, W | 1 |
| Arakawa, N; Drexler, H; Hornig, B | 1 |
| Chien, Y; Frohlich, ED; MacPhee, AA; Pegram, BL | 1 |
2 review(s) available for quinaprilat and Cardiac Failure
| Article | Year |
|---|---|
Quinaprilat: a review of its pharmacokinetics, pharmacodynamics, toxicological data and clinical application.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Clinical Trials as Topic; Drug Evaluation, Preclinical; Female; Half-Life; Heart Failure; Humans; Hypertension; Pregnancy; Tetrahydroisoquinolines | 2009 |
Effect of ACE inhibition on endothelial dysfunction in patients with chronic heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Coronary Disease; Endothelium, Vascular; Heart Failure; Humans; Isoquinolines; Nitric Oxide; Tetrahydroisoquinolines; Treatment Outcome; Vasodilation | 1998 |
3 trial(s) available for quinaprilat and Cardiac Failure
| Article | Year |
|---|---|
Haemodynamic effects of intravenous quinaprilat in comparison to sodium nitroprusside in patients with chronic heart failure.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Heart Failure; Humans; Infusions, Intravenous; Middle Aged; Nitroprusside; Stroke Volume; Tetrahydroisoquinolines; Vasodilator Agents | 2007 |
Hemodynamic and hormonal effects of quinaprilat in patients with congestive heart failure.
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Isoquinolines; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin; Tetrahydroisoquinolines | 1996 |
[Hemodynamic and humoral effects of parenteral therapy with intravenously administered ACE inhibitor quinaprilat in patients with advanced heart failure].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Catecholamines; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Hormones; Humans; Infusions, Intravenous; Isoquinolines; Male; Middle Aged; Peptidyl-Dipeptidase A; Renin; Tetrahydroisoquinolines | 1996 |
3 other study(ies) available for quinaprilat and Cardiac Failure
| Article | Year |
|---|---|
Optimizing ischemia/reperfusion in the failing rat heart--improved myocardial protection with acute ACE inhibition.
Topics: Adenine Nucleotides; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiotonic Agents; Heart; Heart Arrest, Induced; Heart Failure; Hemodynamics; Isoquinolines; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Organ Culture Techniques; Phosphocreatine; Rats; Rats, Wistar; Tetrahydroisoquinolines | 2002 |
The pharmacokinetics of quinapril and quinaprilat in patients with congestive heart failure.
Topics: Administration, Oral; Aged; Aging; Angiotensin-Converting Enzyme Inhibitors; Drug Administration Schedule; Female; Half-Life; Heart Failure; Humans; Isoquinolines; Kidney Function Tests; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines | 1994 |
Quinaprilat increases total body vascular compliance in rats with myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Central Venous Pressure; Compliance; Heart Failure; Hemodynamics; Isoquinolines; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Tetrahydroisoquinolines; Vasodilation; Veins | 1992 |